Development of an instrument to measure quality of life in children with bronchopulmonary dysplasia
Completed
- Conditions
- chronic lung disease after preterm birthhyalin membrane disease1002892010028971
- Registration Number
- NL-OMON35138
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 91
Inclusion Criteria
Children that were discharged from the neonatal intensive care unit of the UMCT between 2003 and 2007, that met the current criteria for BPD.
Exclusion Criteria
In case of death of the child or missing of current contact information.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The developed disease specific questionnaire for BPD.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Outcome value of lung function tests (spirometry), ecg characteristics, length<br /><br>and weight, bloodpressure, IQ-test and of the questionnaires for behaviour and<br /><br>development.<br /><br>Outcome of the questionnaire about medical information and familysituation and<br /><br>-information that is relevant to the outcome of the study.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are associated with chronic lung disease in preterm infants with BPD?
How does the BPD-specific QoL instrument compare to generic pediatric pulmonary function assessments?
Which biomarkers correlate with long-term quality of life outcomes in BPD survivors?
What adverse effects are reported in observational BPD studies using non-invasive QoL metrics?
Are there validated alternative QoL assessment tools for pediatric chronic respiratory conditions like hyalin membrane disease?